Professional Essentials

  • US Professional News
  • FULLTEXT

Physicians favor research from rich countries

  • US Professional News
  • FULLTEXT

AMA seeks simpler e-prescribing

  • US Professional News
  • FULLTEXT

Physicians behaving badly: what are grounds for termination?

  • US Professional News
  • FULLTEXT

AHA president suffers heart attack at AHA meeting

  • Patients Will Be Asking

Patients Will Be Asking: Is my heart healthy enough to have sex?

  • Patients Will Be Asking

Patients Will Be Asking: Is kratom safe?

View more

New in Dermatology

  • Clinical Essentials from Br J Cancer
  • 1 comment

Melanoma: TERT mutation, expression have limited prognostic value

Only expression of TERT protein was linked to reduced survival.

  • Clinical Essentials from Br J Dermatol
  • no comment

Psoriasis: narrow-band UVB accelerates response to FAEs

A short course of UBV appears to improve the slow onset of action associated with FAEs.

  • Clinical Essentials from JAMA Dermatol
  • no comment

Dermatomyositis: factors associated with skin disease remission

Findings suggest a need for better therapies.

  • Clinical Essentials from Ann Oncol
  • 1 comment
  • FULLTEXT

High-risk melanoma: circulating tumor DNA predicts relapse

Minimally invasive test can indicate need for adjuvant therapy.

  • Clinical Essentials from Eur Ann Otorhinolaryngol Head Neck Dis
  • 1 comment

Head neck cSCC: 5 prognostic factors for patients with parotid metastasis

Metastasis is rare, but carries a poor prognosis.

Skin Disease Vitals for November 2017
  • Vitals
  • 1 comment

Skin Disease Vitals for November 2017

Ixekizumab psoriasis efficacy confirmed | Secukinumab vs ustekinumab in QoL | Phase 3 adalimumab results for nail psoriasis.

  • Clinical Essentials from J Dermatolog Treat
  • no comment

Psoriasis: IL-17/IL-23 inhibitors top older biologics

A systematic review of 12 active-comparator studies involving over 12K patients.

  • Clinical Essentials from Arthritis Care Res (Hoboken)
  • 1 comment

Hip/knee arthroplasty: fears of infliximab-related infection risk may be unfrounded

Study finds no increased risk for infection with infliximab stopped less than 4 wk before surgery.

  • Clinical Essentials from Eur J Cancer
  • 1 comment

Vismodegib for BCC: open-label STEVIE trial assesses tolerability

Primary analysis of largest study ever conducted of vismodegib in patients with BCC.

  • Clinical Essentials from Dermatol Ther
  • 1 comment

Skin warts: how do thermotherapy and cryotherapy compare?

Study shows 20% scarring rate with thermotherapy.

  • Clinical Essentials from J Am Acad Dermatol
  • 1 comment

Atopic dermatitis tied to lower sleep efficiency in children

Sleep disturbances affect 60% of pediatric patients with AD.

  • Clinical Essentials from Dermatol Surg
  • 1 comment

Thin melanoma: 2016 NCCN guidelines improve SLNB selection

Updated recommendations incorporate predictors of SLN positivity.

  • Clinical Essentials from N Engl J Med
  • 1 comment

New drug for psoriatic arthritis

Results of a phase 3 study.

  • Clinical Essentials from N Engl J Med
  • 1 comment

Year-long extension trial finds tofacitinib effective in psoriatic arthritis

This study was an extension of a similar study reported today.